Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 2
2014 1
2019 2
2020 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
IL-2-based approaches to Treg enhancement.
Harris F, Berdugo YA, Tree T. Harris F, et al. Among authors: berdugo ya. Clin Exp Immunol. 2023 Mar 16;211(2):149-163. doi: 10.1093/cei/uxac105. Clin Exp Immunol. 2023. PMID: 36399073 Free PMC article. Review.
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
Di Mambro A, Arroyo-Berdugo Y, Fioretti T, Randles M, Cozzuto L, Rajeeve V, Cevenini A, Austin MJ, Esposito G, Ponomarenko J, Lucas CM, Cutillas P, Gribben J, Williams O, Calle Y, Patel B, Esposito MT. Di Mambro A, et al. Among authors: arroyo berdugo y. Oncogene. 2023 Dec;42(50):3670-3683. doi: 10.1038/s41388-023-02840-1. Epub 2023 Oct 27. Oncogene. 2023. PMID: 37891368 Free PMC article.
Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression.
Penas C, Arroyo-Berdugo Y, Apraiz A, Rasero J, Muñoa-Hoyos I, Andollo N, Cancho-Galán G, Izu R, Gardeazabal J, Ezkurra PA, Subiran N, Alvarez-Dominguez C, Alonso S, Bosserhoff AK, Asumendi A, Boyano MD. Penas C, et al. Among authors: arroyo berdugo y. Sci Rep. 2023 Jun 12;13(1):9561. doi: 10.1038/s41598-023-36684-2. Sci Rep. 2023. PMID: 37308689 Free PMC article.
RKIP Regulates Differentiation-Related Features in Melanocytic Cells.
Penas C, Apraiz A, Muñoa I, Arroyo-Berdugo Y, Rasero J, Ezkurra PA, Velasco V, Subiran N, Bosserhoff AK, Alonso S, Asumendi A, Boyano MD. Penas C, et al. Among authors: arroyo berdugo y. Cancers (Basel). 2020 Jun 3;12(6):1451. doi: 10.3390/cancers12061451. Cancers (Basel). 2020. PMID: 32503139 Free PMC article.
Imaging Mass Spectrometry-Based Lipidomic Approach to Classification of Architectural Features in Nevi.
Garate J, Lage S, Fernández R, Velasco V, Abad B, Asumendi A, Gardeazabal J, Arroyo-Berdugo Y, Rodríguez MÁ, Artola JL, Zabalza I, Ochoa B, Fernández JA, Boyano MD. Garate J, et al. Among authors: arroyo berdugo y. J Invest Dermatol. 2019 Sep;139(9):2055-2058.e7. doi: 10.1016/j.jid.2019.01.031. Epub 2019 Mar 13. J Invest Dermatol. 2019. PMID: 30878679 Free article. No abstract available.
High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML.
Arroyo-Berdugo Y, Sendino M, Greaves D, Nojszewska N, Idilli O, So CW, Di Silvio L, Quartey-Papafio R, Farzaneh F, Rodriguez JA, Calle Y. Arroyo-Berdugo Y, et al. Cancers (Basel). 2023 Mar 27;15(7):1988. doi: 10.3390/cancers15071988. Cancers (Basel). 2023. PMID: 37046649 Free PMC article.
Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.
Arroyo-Berdugo Y, Alonso S, Ribas G, Ibarrola-Villava M, Peña-Chilet M, Martínez-Cadenas C, Gardeazabal J, Ratón-Nieto JA, Sánchez-Díez A, Careaga JM, Pérez-Yarza G, Carretero G, Martín-González M, Gómez-Fernández C, Nagore E, Asumendi A, Boyano MD. Arroyo-Berdugo Y, et al. PLoS One. 2014 Apr 17;9(4):e95522. doi: 10.1371/journal.pone.0095522. eCollection 2014. PLoS One. 2014. PMID: 24743186 Free PMC article.
12 results